Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-24 @ 3:31 PM
NCT ID:
NCT00989092
Eligibility Criteria:
Inclusion Criteria:
* nonmyeloid malignancies (including lymphocytic leukemias)
* anemia (hemoglobin concentration less than or equal to 11.0 g/dL) due to cancer and/or previous chemotherapy or radiotherapy
* Eastern Cooperative Oncology Group performance status of 0 to 2
* adequate liver and renal functions
* 18 years or older
Exclusion Criteria:
* history of recombinant human erythropoietin therapy, cytotoxic chemotherapy, or more than 30 Gy radiotherapy to the whole pelvis within 4 weeks before screening
* acute myelogenous leukemia, chronic myelogenous leukemia, or myelodysplastic syndrome
* known hematologic disorders that could cause anemia
* inflammatory or cardiac disorders
* previous positive antibody response to any erythropoietic agent
* history of pure red cell aplasia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00989092
Study Brief:
Protocol Section:
NCT00989092